Taimei’s IWRS system enhances blind clinical trial efficiency and accuracy
Reading Time: 4 minutes Blinding is an important measure to control trial bias in clinical trials, and blindness maintenance is also the most basic requirement for randomized systems. However, in a trial, different stages and different drugs may have different blinding requirements.